NCT03696966 (KAMEL) is a NA clinical trial of Portion-Controlled Meals in Obesity, sponsored by University of Kansas Medical Center.

Who is sponsoring NCT03696966?

NCT03696966 is sponsored by University of Kansas Medical Center.

What drugs are being tested in NCT03696966?

Interventions in NCT03696966: Portion-Controlled Meals, Low-Calorie Diet, Intermittent Very-Low Calorie Diet.

What condition does NCT03696966 study?

NCT03696966 studies Obesity, Weight Loss.

Is NCT03696966 still recruiting?

NCT03696966 is currently completed. Last updated 22 January 2019.

Last reviewed 2019-01-22 · How we verify

NCT03696966: KAMEL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

KU Alternate Meal Energy Level Study

Completed NA Last updated 22 January 2019

What this trial tests

NA trial testing Portion-Controlled Meals in Obesity in 35 participants. Completed in 1 November 2018.

Timeline

16 January 2018

Primary endpoint
4 October 2018

1 November 2018

Quick facts

Lead sponsor	University of Kansas Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	35
Start date	16 January 2018
Primary completion	4 October 2018
Estimated completion	1 November 2018
Sites	1 location across United States

Drugs / interventions tested

Portion-Controlled Meals
Low-Calorie Diet
Intermittent Very-Low Calorie Diet

Conditions studied

Obesity — all drugs for Obesity →
Weight Loss — all drugs for Weight Loss →

Sponsor

University of Kansas Medical Center

Who can join

Adults 21 to 65, any sex, with Obesity or Weight Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Compare intermittent versus continuous calorie restriction to learn more about these eating plans and determine whether they are useful and effective to lose weight and keep it off.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Intermittent and continuous energy restriction result in similar weight loss, weight loss maintenance, and body composition changes in a 6 month randomized pilot study.
Steger FL, Donnelly JE, Hull HR, Li X, et al · · 2021 · cited 32× · PMID 33305526 · DOI 10.1111/cob.12430
Comparing caloric restriction regimens for effective weight management in adults: a systematic review and network meta-analysis.
Huang J, Li Y, Chen M, Cai Z, et al · · 2024 · cited 6× · PMID 39327619 · DOI 10.1186/s12966-024-01657-9

Verify or expand the search:

Other trials of Portion-Controlled Meals

Trials testing the same drug.

NCT03874988 — Building an Evidence Base for Weight Loss Strategies Among Those With Chronic SCI-The GLB-SCI+ · NA · completed

Other recruiting trials for Obesity

Currently open trials in the same condition.

NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting

Other University of Kansas Medical Center trials

Trials by the same sponsor.

NCT06636214 — Adapting Changing Talk: Online (CHATO) to CHATO-Inclusive · NA · not yet recruiting
NCT07528963 — KanSurvive 2.0: Testing Enhanced Models of Cancer Survivorship Care for Rural Cancer Survivors in Primary Care Practice · NA · enrolling by invitation
NCT07463755 — Low-Fidelity Driving Simulator Training in Parkinson's Disease. · NA · not yet recruiting
NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
NCT07491510 — Improving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03696966 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Kansas Medical Center
Last refreshed: 22 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03696966.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing